智通财经获悉，周四，Allurion(ALUR.US)股价收涨超21%；截至发稿，股价在盘后交易中进一步飙升80%，此前有消息称该公司计划将 ...

In Malaysia, cases of overweight and obesity are now increasing at an alarming rate. Photo by Jeslyn Teh. The Allurion intragastric balloon (IGB) is inserted through the mouth into the patient's ...

Along with a Virtual Care Suite that provide tools for healthcare professionals to monitor and modify treatments, the Allurion Program has a swallowable gastric balloon that calls for no surgical ...

It seeks to establish this mix as a standard for treatment of obesity. Along with a Virtual Care Suite that provide tools for healthcare professionals to monitor and modify treatments, the Allurion ...

ALUR now holds 20 U.S. patents and 59 globally. The Allurion Program combines the swallowable, procedure-free Allurion Gastric Balloon with the Allurion Virtual Care Suite, including a mobile app ...

NATICK, Mass., January 24, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today ...

The company plans to evaluate its Allurion Program with GLP-1 agonists to address muscle loss concerns and promote healthier weight loss. Allurion entered into a securities purchase agreement to ...

NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today ...

Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less TM gastric ...